Maintenance Therapy for Inflammatory Bowel Disease: What Really Works
Author(s) -
Lloyd R. Sutherland
Publication year - 1997
Publication title -
canadian journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
eISSN - 2291-2797
pISSN - 2291-2789
DOI - 10.1155/1997/359020
Subject(s) - medicine , inflammatory bowel disease , disease , randomized controlled trial , quality of life (healthcare) , odds , intensive care medicine , clinical trial , maintenance therapy , odds ratio , surgery , chemotherapy , logistic regression , nursing
The propensity of inflammatory bowel disease sufferers to experience recurrent episodes or disease flares is well documented. Until a cure can be found, strategies to lengthen the period of remission offer the greatest opportunity to reduce morbidity and enhance patient quality of life. Therapies that have been shown in randomized, controlled, double-blind clinical trials to either lengthen the time of remission or improve the odds of staying in remission during a set time interval are required.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom